FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medicine, namely to therapy and endocrinology, and deals with treatment of diseases, associated with impairment of endocannabinoid system. For this purpose medication based on antibodies against human cannabinoid receptor, obtained in the process of multiple successive dilution of said antibodies and intermediate external mechanical influence, is claimed.
EFFECT: introduction of such medication ensures normalisation of metabolic disorders, including obesity.
5 cl, 2 dwg, 6 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING OBESITY AND ASSOCIATED METABOLIC DISORDERS | 2013 |
|
RU2582393C2 |
| METHOD OF TREATING OBESITY AND ACCOMPANYING METABOLIC DISORDERS AND MEDICATION FOR TREATING OBESITY AND ACCOMPANYING METABOLIC DISORDERS | 2010 |
|
RU2552221C2 |
| METHOD OF INFLUENCING FUNCTIONAL ACTIVITY OF CANNABINOID RECEPTOR | 2013 |
|
RU2557971C2 |
| METHOD OF TREATING PATHOLOGICAL SYNDROME AND DRUG OF CENTRAL AND PERIPHERAL ACTION FOR TREATING PATHOLOGICAL SYNDROME | 2011 |
|
RU2610438C2 |
| METHOD OF TREATING VEGETOVASCULAR DYSTONIA AND PHARMACEUTICAL COMPOSITION FOR TREATING VEGETOVASCULAR DYSTONIA | 2010 |
|
RU2523557C2 |
| METHOD OF TREATMENT AND PREVENTION OF ARTERIAL HYPERTENSION AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ARTERIAL HYPERTENSION | 2010 |
|
RU2525156C2 |
| METHOD OF TREATING CHRONIC CARDIAC FAILURE AND PHARMACEUTICAL COMPOSITION FOR TREATING CHRONIC CARDIAC FAILURE | 2011 |
|
RU2523451C2 |
| METHOD OF TREATING CHRONIC HEART FAILURE AND PHARMACEUTICAL COMPOSITION FOR COMPLEX THERAPY OF CHRONIC HEART FAILURE | 2010 |
|
RU2525155C2 |
| MEDICINAL AGENT FOR TREATING INFECTIOUS DISEASES | 2014 |
|
RU2579262C1 |
| THERAPEUTIC AGENT | 2013 |
|
RU2595809C2 |
